0001127602-18-007606.txt : 20180221 0001127602-18-007606.hdr.sgml : 20180221 20180221181023 ACCESSION NUMBER: 0001127602-18-007606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180216 FILED AS OF DATE: 20180221 DATE AS OF CHANGE: 20180221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stejbach Mark CENTRAL INDEX KEY: 0001487937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 18629889 MAIL ADDRESS: STREET 1: C/O TENGION, INC. STREET 2: 2900 POTSHOP LANE, SUITE 100 CITY: EAST NORRITON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-02-16 0001520262 Alkermes plc. ALKS 0001487937 Stejbach Mark 852 WINTER ST. WALTHAM MA 02451 1 SVP/Chief Comm Off, Alks Inc Ordinary Shares 2018-02-16 4 M 0 10880 17.30 A 54893 D Ordinary Shares 2018-02-16 4 S 0 10880 70.5048 D 44013 D Ordinary Shares 2018-02-17 4 M 0 3000 0 A 47013 D Ordinary Shares 2018-02-17 4 F 0 884 67.26 D 46129 D Employee Stock Option (Right to Buy) 17.30 2018-02-16 4 M 0 10880 0 D 2022-03-07 Ordinary Shares 10880 5780 D Employee Stock Option (Right to Buy) 67.26 2018-02-16 4 A 0 54500 0 A 2019-02-16 2028-02-16 Ordinary Shares 54500 54500 D Restricted Stock Unit Award 0 2018-02-16 4 A 0 13500 0 A 2019-02-16 Ordinary Shares 13500 13500 D Restricted Stock Unit Award 0 2018-02-17 4 M 0 3000 0 D 2018-02-17 Ordinary Shares 3000 9000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/5/17. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/5/17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.14 to $70.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. Shares subject to the stock option award vest in four equal annual installments commencing on 2/16/2019. Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. /s/ Jennifer Baptiste, attorney-in-fact for Mark Stejbach 2018-02-21